Shanghai Fosun Pharmaceutical (Group) Co., Ltd. SEC EDGAR Filings (CIK 0001615258)

SEC EDGAR filings, ownership reports, and insider transactions for Shanghai Fosun Pharmaceutical (Group) Co., Ltd..

Business address
Building A, No. 1289 Yishan Road, Shanghai, China, 200233
Top holdings (ownership)
NATR
Top holdings (Schedule 13D)
NATR
State of incorporation
China
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has filed 46 SEC EDGAR filings since 04 Aug 2014

Latest Filings

Recent SEC filings for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. including 4, SCHEDULE 13D/A, N-PX and more.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 27 Jun 2025 27 Jun 2025 001-34483
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 27 Jun 2025
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 09 Jun 2025
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 17 Oct 2024 15 Oct 2024 001-34483
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 15 Oct 2024 06 Sep 2024 001-34483
N-PX Open N-PX document View SEC filing for N-PX 30 Aug 2024 30 Sep 2023 028-18303
N-PX Open N-PX document View SEC filing for N-PX 29 Aug 2024 30 Jun 2024 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 08 Nov 2023 30 Sep 2023 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 14 Aug 2023 30 Jun 2023 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 28 Apr 2023 31 Mar 2023 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 10 Feb 2023 31 Dec 2022 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 14 Nov 2022 30 Sep 2022 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 10 Aug 2022 30 Jun 2022 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 11 May 2022 31 Mar 2022 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 10 Feb 2022 31 Dec 2021 028-18303
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 24 Jan 2022 12 Apr 2021 001-34483
13F-NT Open 13F-NT document View SEC filing for 13F-NT 12 Nov 2021 30 Sep 2021 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 12 Aug 2021 30 Jun 2021 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 11 May 2021 31 Mar 2021 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 05 Feb 2021 31 Dec 2020 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 12 Nov 2020 30 Sep 2020 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 12 Aug 2020 30 Jun 2020 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 11 May 2020 31 Mar 2020 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 14 Feb 2020 31 Dec 2019 028-18303
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 13 Dec 2019 11 Dec 2019 001-34483
13F-NT Open 13F-NT document View SEC filing for 13F-NT 12 Nov 2019 30 Sep 2019 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 12 Aug 2019 30 Jun 2019 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 10 May 2019 31 Mar 2019 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 31 Jan 2019 31 Dec 2018 028-18303
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 06 Dec 2018 04 Dec 2018 001-36577
3/A Open 3/A document View SEC filing for 3/A OWNERSHIP DOCUMENT 06 Dec 2018 25 Jul 2017 001-36577
13F-NT Open 13F-NT document View SEC filing for 13F-NT 09 Nov 2018 30 Sep 2018 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 13 Aug 2018 30 Jun 2018 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 08 May 2018 31 Mar 2018 028-18303
13F-NT Open 13F-NT document View SEC filing for 13F-NT 09 Feb 2018 31 Dec 2017 028-18303
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 07 Feb 2018
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 31 Aug 2017
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 18 Aug 2017 25 Jul 2017 001-36577
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 20 Jan 2017
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 28 Jan 2016
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 15 May 2015
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 17 Mar 2015
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD SC 13DA 8-25-2014 (NATURE?S SUNSH 02 Sep 2014
3/A Open 3/A document View SEC filing for 3/A FORM 3/A 02 Sep 2014 25 Jul 2014 001-34483
3 Open 3 document View SEC filing for 3 FORM 3 04 Aug 2014 25 Jul 2014 001-34483
SC 13D Open SC 13D document View SEC filing for SC 13D SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD SC 13D 7-25-2014 (NATURE'S SUNSHI 04 Aug 2014

About this filer

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. files with the SEC under CIK 0001615258. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages